{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:46:14Z","timestamp":1793094374805,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.eururo.2014.03.003","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T07:31:59Z","timestamp":1395300719000},"page":"529-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"title":["A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma"],"prefix":"10.1016","volume":"66","author":[{"given":"Jeffrey J.","family":"Leow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Martin-Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 P.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni K.","family":"Choueiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Bellmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.03.003_bib0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 update","volume":"63","author":"Roupret","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data","volume":"48","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2013.08.033","article-title":"Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0020","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/pd.214","article-title":"Normal and abnormal development of the urogenital tract","volume":"21","author":"Cuckow","year":"2001","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.eururo.2014.03.003_bib0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejcb.2004.12.011","article-title":"Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?","volume":"84","author":"Riedel","year":"2005","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jcp.20140","article-title":"Spreading of embryologically distinct urothelial cells is inhibited by SPARC","volume":"202","author":"Hudson","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0040","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/sj.onc.1206964","article-title":"Distinct patterns of microsatellite instability are seen in tumours of the urinary tract","volume":"22","author":"Catto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.eururo.2014.03.003_bib0045","first-page":"6796","article-title":"Frequent microsatellite instability in sporadic tumors of the upper urinary tract","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2014.03.003_bib0050","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","article-title":"Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma","volume":"23","author":"Catto","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0055","first-page":"547","article-title":"Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas","volume":"18","author":"Kunze","year":"2006","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.eururo.2014.03.003_bib0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.seminoncol.2012.08.007","article-title":"New therapeutic challenges in advanced bladder cancer","volume":"39","author":"Bellmunt","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2008.06.013","article-title":"FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours","volume":"55","author":"van Oers","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/jco.2014.32.4_suppl.309","article-title":"Targeted sequencing of upper tract urothelial carcinoma [abstract]","volume":"32","author":"Sfakianos","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0080","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2014.03.003_bib0085","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2014.03.003_bib0090","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.eururo.2014.03.003_bib0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2014.03.003_bib0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.eururo.2014.03.003_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.eururo.2014.03.003_bib0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/sim.4780140406","article-title":"A random-effects regression model for meta-analysis","volume":"14","author":"Berkey","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.eururo.2014.03.003_bib0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2014.03.003_bib0120","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.2004.09.043","article-title":"Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group","volume":"22","author":"Bamias","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1442-2042.2004.00841.x","article-title":"Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer","volume":"11","author":"Suzuki","year":"2004","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","article-title":"Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract","volume":"68","author":"Kwak","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.03.003_bib0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000092930","article-title":"Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract","volume":"77","author":"Lee","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2014.03.003_bib0140","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","article-title":"Adjuvant methotrexate, vinblastine, Adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma","volume":"15","author":"Soga","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration","volume":"182","author":"Hellenthal","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0150","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1002\/cncr.26172","article-title":"Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study","volume":"117","author":"Vassilakopoulou","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.03.003_bib0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00345-011-0775-z","article-title":"The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study","volume":"30","author":"Kawashima","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0160","doi-asserted-by":"crossref","first-page":"686","DOI":"10.7150\/jca.7326","article-title":"The efficacy of adjuvant chemotherapy for locally advanced upper tract urothelial cell carcinoma","volume":"4","author":"Kim","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.eururo.2014.03.003_bib0165","doi-asserted-by":"crossref","unstructured":"Yafi FA, Tanguay S, Rendon R, et al. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome. Urol Oncol 2014;32:31.e17\u201324.","DOI":"10.1016\/j.urolonc.2012.11.014"},{"key":"10.1016\/j.eururo.2014.03.003_bib0170","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1464-410X.2011.10075.x","article-title":"Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration","volume":"108","author":"Youssef","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2014.03.003_bib0175","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","article-title":"Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma","volume":"116","author":"Matin","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.03.003_bib0180","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"The Upper Tract Urothelial Carcinoma Collaboration. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.03.003_bib0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000282755","article-title":"Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract","volume":"55","author":"Igawa","year":"1995","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2014.03.003_bib0190","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/cncr.27751","article-title":"A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results","volume":"119","author":"Siefker-Radtke","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.03.003_bib0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/jco.2012.30.5_suppl.261","article-title":"Neoadjuvant chemotherapy with DDMVAC and bevacizumab in high-risk urothelial cancer: results from a phase II trial at the M.D. Anderson Cancer Center [abstract]","volume":"30","author":"Siefker-Radtke","year":"2012","journal-title":"J Clin Oncol"},{"issue":"Suppl 6","key":"10.1016\/j.eururo.2014.03.003_bib0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/jco.2013.31.6_suppl.311","article-title":"Survival outcomes in patients undergoing neoadjuvant chemotherapy for upper tract urothelial cell carcinoma [abstract]","volume":"31","author":"Porten","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0205","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","article-title":"Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy","volume":"58","author":"Kaag","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0210","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.03.003_bib0215","doi-asserted-by":"crossref","unstructured":"Kaag M, Trost L, Thompson RH, et al. Pre-operative predictors of renal function decline following radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int. In press. http:\/\/dx.doi.org\/10.1111\/bju.12597.","DOI":"10.1111\/bju.12597"},{"key":"10.1016\/j.eururo.2014.03.003_bib0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/0003-4819-155-1-201107050-00006","article-title":"Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study","volume":"155","author":"Dechartres","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2014.03.003_bib0225","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1200\/JCO.2011.34.8433","article-title":"Treatment of patients with metastatic urothelial cancer \u201cunfit\u201d for cisplatin-based chemotherapy","volume":"29","author":"Galsky","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11934-013-0307-z","article-title":"The role of systemic chemotherapy in management of upper tract urothelial cancer","volume":"14","author":"Gayed","year":"2013","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.eururo.2014.03.003_bib0235","doi-asserted-by":"crossref","unstructured":"Johnson DC, Nielsen ME, Matthews J, et al. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity. BJU Int. In press. http:\/\/dx.doi.org\/10.1111\/bju.12585.","DOI":"10.1111\/bju.12585"},{"key":"10.1016\/j.eururo.2014.03.003_bib0240","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2014.01.014","article-title":"The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study","volume":"66","author":"Gandaglia","year":"2014","journal-title":"Eur Urol"},{"issue":"Suppl 6","key":"10.1016\/j.eururo.2014.03.003_bib0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/jco.2013.31.6_suppl.311","article-title":"Survival outcomes in patients undergoing neoadjuvant chemotherapy for upper tract urothelial cell carcinoma [abstract]","author":"Porten","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0250","doi-asserted-by":"crossref","unstructured":"Reardon ZD, Patel SG, Zaid HB, et al. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Eur Urol. In press. http:\/\/dx.doi.org\/10.1016\/j.eururo.2014.01.009.","DOI":"10.1016\/j.eururo.2014.01.009"},{"key":"10.1016\/j.eururo.2014.03.003_bib0255","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1464-410X.2012.11413.x","volume":"110","author":"Birtle","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2014.03.003_bib0260","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1200\/JCO.2008.18.2071","article-title":"Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803","volume":"27","author":"Bertagnolli","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.03.003_bib0265","doi-asserted-by":"crossref","first-page":"446","DOI":"10.6004\/jnccn.2013.0059","article-title":"Bladder cancer","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl 4","key":"10.1016\/j.eururo.2014.03.003_bib0270","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/jco.2014.32.4_suppl.326","article-title":"Neoadjuvant accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) in patients with high-grade upper-tract urothelial carcinoma [abstract]","volume":"32","author":"Hoffman-Censits","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814002127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814002127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:03:26Z","timestamp":1759583006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814002127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0302283814002127"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.03.003","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}